AARD
NASDAQ · Pharmaceuticals
Aardvark Therapeutics Inc
$7.90
+0.60 (+8.22%)
Open$7.46
Previous Close$7.30
Day High$8.12
Day Low$7.31
52W High$17.94
52W Low$3.35
Volume—
Avg Volume114.9K
Market Cap159.75M
P/E Ratio—
EPS$-3.21
SectorPharmaceuticals
Analyst Ratings
Buy
18 analysts
Price Target
+232.2% upside
Current
$7.90
$7.90
Target
$26.24
$26.24
$21.03
$26.24 avg
$41.18
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 44.31M | 42.19M | 44.45M |
| Net Income | 12.13M | 10.07M | 10.99M |
| Profit Margin | 27.4% | 23.9% | 24.7% |
| EBITDA | 17.61M | 17.80M | 18.44M |
| Free Cash Flow | 9.43M | 7.96M | 8.12M |
| Rev Growth | -1.8% | +11.1% | +14.2% |
| Debt/Equity | 0.60 | 0.62 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |